Valproate and neuroprotective effects for bipolar disorder

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Valproate is a widely used anticonvulsant and mood stabilizer for bipolar disorder.
• Its precise mechanism of action is not fully understood, but alterations in gene expression are implicated in chronic treatment.
• Emerging evidence highlights valproate's neuroprotective and neurotrophic properties.

Purpose of the Study:

• To explore the neuroprotective and neurotrophic effects of valproate.
• To investigate the role of gene expression regulation in valproate's therapeutic action.
• To provide evidence supporting valproate's efficacy in treating bipolar disorder.

Main Methods:

• Review of neuroimaging studies on brain neurochemistry in bipolar disorder.
• Cellular studies demonstrating valproate's protection against excitotoxicity and apoptosis.
• Genetic analyses examining the impact of valproate on transcription factors like activator protein 1 (AP-1).

Main Results:

• Valproate demonstrated protective effects on neuronal cells against glutamate-induced excitotoxicity and endoplasmic reticulum stress-induced apoptosis.
• Neuroimaging studies suggest bipolar disorder is linked to altered neuronal viability and function.
• Valproate and lithium influence DNA binding to transcription factors, indicating a role in gene expression regulation.

Conclusions:

• Valproate exhibits significant neuroprotective and neurotrophic actions relevant to bipolar disorder treatment.
• Regulation of gene expression and signaling pathways in neuronal circuits is a key aspect of valproate's therapeutic effect.
• These findings support valproate's role as a first-line treatment for bipolar disorder.